Greg Siokas & Cosmos Health

Greg Siokas: Greg Siokas, CEO of Cosmos Health, announced the company's plan to monetize non-core assets, emphasizing the potential to unlock significant value for shareholders through acquisitions or debt reduction.

Cosmos Health: Cosmos Health is exploring the monetization of approximately $20 million in non-core assets to strengthen its balance sheet, fund strategic initiatives, and potentially eliminate debt, which could significantly improve its financial position and market valuation.

Greg Siokas: Greg Siokas, CEO of Cosmos Health, commented on the acquisition, highlighting its role in strengthening the company's transition to proprietary product development and commercialization.

Cosmos Health: Cosmos Health Inc. has strengthened its proprietary IP portfolio and expanded its nanotechnology investment initiatives through the acquisition of a patent application, which is expected to drive long-term shareholder value and support the development of next-generation healthcare products.

Greg Siokas: Greg Siokas, CEO of Cosmos Health>>>, announced the successful testing and strategic importance of extending the C-Scrub brand into the veterinary sector.

Cosmos Health: Cosmos Health is expanding its product line into the animal health market with the launch of C-Scrub Wash 4% for veterinary use, which is expected to open new commercial opportunities and revenue streams for the company.

Greg Siokas: Greg Siokas, CEO of Cosmos Health, expressed the company's preference to regain compliance without a reverse stock split, outlining their strategy to enhance shareholder value.

Cosmos Health: Cosmos Health received an additional 180-day extension from Nasdaq-100 to regain compliance with the minimum bid price requirement, which is positive for its continued listing but highlights ongoing stock price challenges.

Greg Siokas: Greg Siokas>>>, CEO of Cosmos Health>>>, commented on the expansion, highlighting its importance for the company's international growth strategy and revenue goals.

Cosmos Health: Cosmos Health has significantly expanded the distribution of its proprietary brand, Sky Premium Life, across all 27 European Union Member States through Skroutz, which is a key milestone in its international growth strategy, enhancing brand visibility and supporting revenue growth.